|
|
 |
|
Viewing report
|
|
|
|
Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
GlobalData, Jan 2012, Pages: 248
Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Summary
GlobalData’s new report, “Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Immuno Chemistry market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within nine market categories – Disease Specific Immunochemistry, Endocrinology Tests, Immunochemistry Rapid Tests, Immunochemistry Analyzers, Organ Function Assays, Anemia / Vitamin Tests, Therapeutic Drug Monitoring, Specific Proteins and Drugs of Abuse / Toxicology. The report also provides company shares and distribution shares data for the overall Immuno Chemistry market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.
Scope
- Market size data for Immuno Chemistry market categories – Disease Specific Immunochemistry, Endocrinology Tests, Immunochemistry Rapid Tests, Immunochemistry Analyzers, Organ Function Assays, Anemia / Vitamin Tests, Therapeutic Drug Monitoring, Specific Proteins and Drugs of Abuse / Toxicology.
- Annualized market revenues ($m) data for each of the segments and sub-segments within the nine market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.
- 2010 company shares and distribution shares data for the overall Immuno Chemistry market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Immuno Chemistry market in BRICS.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc., bioMerieux S.A., Phadia AB, Alere Inc., Bio-Rad Laboratories, Inc., Transasia Bio-Medicals Ltd. and DiaSorin S.p.A.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Immuno Chemistry competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
|
|
|
|
